// App-Quantinova.ai

6276 : Real-world prevalence of MSI/MMR testing for patients with recurrent or advanced endometrial cancer in Europe

Researchers

Presenter

  • Jingchuan Zhang

Principal Investigators

  • Sneha S. Kelkar

  • Vimalanand S. Prabhu

  • Shelby Corman

  • Lucy Qiao

  • Véronique Grall

  • Nicola Miles

Medical Centers

  • Eisai Inc, Woodcliff Lake, NJ

  • Open Health, Bethesda, MD

  • Merck Sharp & Dohme Corp., Kenilworth, NJ

  • M3 Clinical Data Services, Abingdon, United Kingdom

Locations

  • United Kingdom

Companies

  • Eisai Inc.

  • Merck Sharp & Dohme

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Endometrial Cancer

Biomarkers

  • Cluster of Differentiation 206

  • Microsatellite instability

  • DNA mismatch repair status

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multicenteric

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved